Hyderabad-based Bharat Biotech's Covid-19 vaccine Covaxin has received an extension of shelf life for up to 12 months from the date of manufacturing India's pharmaceuticals and medical regulatory body.

"The Central Drugs Standard Control Organisation (CDSCO) has approved the extension of shelf life of COVAXIN up to 12 months, from the date of manufacture," said Bharat Biotech in a statement posted by the biotechnology company on its official Twitter handle.